SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and goutVéronique Vitart, Alan F. Wright, Igor Rudan et al.|Nature Genetics|2008Cited by 806
A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and qualityVal Mann, Stuart H. Ralston|Journal of Clinical Investigation|2001Cited by 469
Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298Fraser P. Coxon, Michael J. Rogers, Miep Helfrich et al.|Journal of Bone and Mineral Research|2000Cited by 360
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptorsAymen I. Idris, Stuart H. Ralston|Nature Medicine|2005Cited by 349